Bispecific ADC Development in Breast Cancer: Emerging Targets and Clinical Progress
Breast cancer is the most common malignancy among women worldwide, with incidence continuing to rise.…
News
Approved Cell and Gene Therapy Drugs in China and Key Differences Between Cell Therapy and Gene Therapy
The landscape of approved cell and gene therapy drugs in China is rapidly evolving, as…
NMPA Approves GSK Depemokimab in China for Severe Eosinophilic Asthma with Twice-Yearly Dosing
On March 27, 2026, the National Medical Products Administration (NMPA) of China officially approved GSK…
Africa Pharmaceutical Industry Challenges — Analysis of Supply Structure and Drug Accessibility
Currently, africa pharmaceutical industry challenges are increasingly recognized as a key issue in the global…
China Pharmaceutical Procurement Process Guide: RFQ, Compliance, Payment & Global Delivery
With the continuous restructuring of the global healthcare supply chain, China has become one of…
Global Advantages of China Pharmaceuticals: How Four Key Factors Improve Drug Accessibility and Supply Efficiency
In the context of continuous development of global healthcare systems, drug accessibility has become a…
ABSK061 Achondroplasia Orphan Drug Designation: Abbisko Therapeutics Advances Targeted Therapy
The ABSK061 achondroplasia orphan drug designation marks an important regulatory milestone in the development of…
Gene Therapy for Beta Thalassemia: Can CRISPR and Gene Addition Achieve Transfusion Independence?
For patients living with transfusion-dependent beta thalassemia (TDT), lifelong blood transfusions have long been the…
ADC Drugs by Target (2026 Update): Full List of Approved ADCs, Pipeline and Trends
Antibody-drug conjugates (ADCs) are one of the fastest-growing classes of therapies in precision oncology. In…
China Generic Drug Market Trends 2026: Opportunities After Blockbuster Drug Patent Expiry
As global drug patents continue to expire, the China Generic Drug Market Trends 2026 indicate…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights